Time to Ditch Clarithromycin for H pylori?

High clarithromycin resistance rates among H pylori isolates in the United States and Europe are grounds for arguing against its use in PPI-based triple therapy, researchers say.

Related Keywords

New York ,United States ,Ann Arbor ,Michigan ,Tennessee ,United Kingdom ,Vanderbilt University ,American ,William Chey ,Judith Kim ,Langone Health ,Division Of Gastroenterology ,Vanderbilt University Medical Center ,Grossman School Of Medicine ,Phathom Pharmaceuticals ,Drug Administration ,Michigan Medicine ,Medscape Medical ,New York City ,American Journal ,Medscape Medical News ,Voquezna Triple Pak ,Voquezna Dual Pak ,Richard Peek ,Helicobacter Pylori ,H Pylori ,Antibiotics ,Igecycline ,Proton Pump Inhibitor ,Cid Suppressive Therapy ,Pi Proton Pump Inhibitor ,Herapy Acid Suppressive ,Europe ,European ,Gastrointestinal Disease ,Di Disease ,